CD34 and myelodysplastic syndrome: In this retrospective study, we propose a FC panel to detect phenotypic aberrancies on CD34+ myeloid progenitors, in combination with the “Ogata score,” to support the diagnosis and prognosis of MDS and explore the correlations with morphologic examination and mutational profile.